Takeda's Next Head May Owe Job To Failed Shionogi Merger Attempt
This article was originally published in PharmAsia News
Executive Summary
Takeda Pharmaceutical's next president and CEO, the first from outside Japan, apparently owes his near future to the failure of a near merger with Shionogi last year.